Mecasermin rinfabate: Phase II data

Top-line data from the double-blind, international Phase II ROPP-2008-01 trial in 121 premature infants born at a gestational age of 23 weeks-27 weeks and 6 days showed that once-daily 250 ug/kg IV

Read the full 320 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE